Mosawin Tablet 5 mg (Mosapride Citrate Hydrate)

Adult dose

Adults: Administer mosapride citrate anhydrous 15 mg daily orally in 3 divided doses before or after meals.

This medication contains lactose, so it should not be used by patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. While taking this medication, be aware that side effects such as diarrhea, loose stools, dry mouth, and fatigue may occur. Serious liver conditions, such as liver dysfunction or fulminant hepatitis, may develop, so if symptoms occur, discontinue the medication immediately and consult a healthcare professional. Hypersensitivity reactions such as rash, urticaria, and edema, as well as hematological abnormalities, gastrointestinal symptoms, palpitations, dizziness, and headache have also been reported, so inform your healthcare provider of any unusual symptoms. It is advisable not to continue using this medication for an extended period if symptoms do not improve after 2 weeks of administration. When taken with anticholinergics, this medication's efficacy may be reduced, so caution and appropriate intervals between dosing should be observed when combined. Safety has not been established during pregnancy, so it should be used cautiously if pregnancy is possible or in pregnant women, and breastfeeding is recommended to be avoided or to stop breastfeeding when using this medication. Safety in children has not been confirmed, so it is advisable not to use it in pediatric patients. Elderly patients may have reduced renal and hepatic function, so their status should be monitored closely and dosage adjusted if necessary. Keep out of reach of children and do not transfer to another container to ensure safety and maintain the quality of the medication. In animal studies, extended high-dose administration has been associated with increased tumor incidence in the liver and thyroid; therefore, long-term high-dose use should be avoided.

• Diarrhea
• loose stools
• dry mouth
• lethargy
• eosinophilia
• increased triglycerides
• elevated AST
• elevated ALT
• elevated ALP
• elevated γ-GTP

This medication should be stored in a tightly closed container that is well-ventilated, at room temperature between 1°C and 30°C. This storage method helps maintain the efficacy of the medication and prevents degradation.

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle